MintNeuro featured prominently this week as CEO and co‑founder Dorian Haci, PhD, promoted the company’s vision for next‑generation neural interfaces and neuro‑aware systems. In an article for Test Labs – Medical Devices’ Outlook magazine, Haci described how advances in neurotechnology, semiconductors, and AI could reshape human–machine interaction and digital healthcare.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company also announced that Haci will be an invited speaker at Hardware Pioneers Max 2026, a major deep‑tech and hardware conference in London scheduled for June 11–12, 2026. His presentation is expected to focus on the convergence of neuroscience, semiconductor technology, and next‑generation hardware for brain–computer interfaces and medtech applications.
Across its communications, MintNeuro emphasized potential applications in treating neurological disorders and mental health conditions, framing brain–computer and neural interfaces as a platform for digital therapeutics and monitoring tools. The company highlighted an ecosystem‑driven strategy at the intersection of medtech, bioelectronics, and semiconductor‑enabled medical devices, although no specific products, revenues, or commercialization timelines were disclosed.
The planned conference appearance targets an audience of deep‑tech founders, IoT innovators, hardware startups, product engineers, and investors, with a clear focus on networking and outreach. Increased visibility at a sector‑specific forum may support MintNeuro’s efforts to build partnerships, attract specialized talent, and engage with investors interested in hardware‑AI convergence and neurotechnology.
While the week’s updates were primarily positioning and thought‑leadership oriented, they reinforced MintNeuro’s long‑term focus on neurotech and AI‑driven interfaces rather than near‑term commercial milestones. Overall, the company used media and conference announcements to strengthen its brand within the neurotechnology ecosystem and to signal ongoing business development activity without providing new financial or operational data.

